January 12, 2023 | Editor: Martin Wennerström
Global investors pressure Glencore over coal production
A group of investors with a combined USD 2.2 trillion in assets under management has submitted a shareholder proposal to the AGM of Glencore Plc, calling for improved disclosure on the commodity giant’s thermal coal operations and the alignment of these with the group’s public commitment to support the Paris Agreement’s goal of limiting global warming to 1.5 °C. The resolution constitutes a significant escalation of pressure on the mining company, which had already seen nearly a quarter of shareholders reject its climate progress report in April 2022. Legal and General Investment Management and HSBC Asset Management are among shareholder signatories to the document, while the proposals were co-filed and facilitated by activist organizations UK NGO ShareAction and the Australasian Centre for Corporate Responsibility.
ESG Today | Bloomberg | Reuters | Seeking Alpha |
India keeps post-privatization free float exemption
The Indian government has announced that the rule exempting state-owned firms from the country’s 25% minimum free float threshold will apply even after privatization. The exemption would be limited for a specified period of time but would otherwise apply regardless of the state’s remaining shareholding. The most immediate beneficiary of the exemption would be IDBI Bank, where the government has initiated the privatization process. IDBI is currently 49.24%-owned by the state and 45.48%-owned by Life Insurance Corporation, with only a 5.28% free float.
Lexology | Bloomberg | Nasdaq | Business Standard
J&J files for IPO of consumer health business Kenvue
Johnson & Johnson (“J&J”) filed an IPO with the U.S. SEC for its consumer health unit, Kenvue, moving closer toward a spinoff. J&J revealed the plan back in November 2021 following similar moves by pharma rivals GSK and Pfizer. The U.S. healthcare giant will list Kenvue on the NYSE under the ticker symbol KVUE with lead underwriters Goldman Sachs Group Inc. and JPMorgan Chase & Co. Furthermore, the new group will include brands such as Tylenol, Listerine, Neutrogena, and Nicorette. J&J will receive all proceeds from the IPO and maintain at least 80% of the voting power of Kenvue’s common stock upon completion of the offering.
Reuters | Bloomberg | Morningstar |
U.S.-listed Chinese stocks jump on signs of regulatory easing
Shares of several Chinese companies, including Alibaba, JD.com, and Pinduoduo, surged in Hong Kong after Chinese regulators reportedly approved a capital raise for Alibaba’s finance affiliate Ant Group. The approval will allow Ant Group to increase the amount of registered capital for its consumer section to CNY 18.5 billion (USD 2.7 billion). Ant Group had attempted to go public in November 2020, but its USD 35 billion IPO was abruptly canceled by the Chinese government. This regulatory green light is seen as a move to ease concerns about China's regulatory crackdown against tech companies in the country.
Recent Content
Governance in Brief – June 8, 2023
European Parliament approves CSDDD The European Parliament has approved the “Corporate Sustainability Due Diligence Directive.” Under the new rules, companies will be required to identify and address the negative impact of their activities and value chains on human rights and the environment. Additionally, companies will need to implement climate transition plans, and, in the case of companies with more than 1,000 employees, tie directors' variable compensation to target achievement.
Governance in Brief – June 1, 2023
Citigroup to IPO Banamex after Mexican gov’t interventions hamper sales deal Citigroup has announced a plan to spin off its Mexican business, Banamex, after a failure to sell the unit to conglomerate Grupo Mexico. Citigroup had been in talks with German Larrea, CEO and Chairman of Grupo Mexico, for over a year in an attempt to orchestrate the sale of the bank, which was first announced at the start of 2022.
Governance in Brief – May 25, 2023
Activist investor pushes for leadership and strategy changes at NRG Energy Activist investor Elliott Investment Management has disclosed a 13% stake in the US-based NRG Energy and called for leadership and operational changes at the company to remedy its “meaningful underperformance.” The investor urged NRG to add independent directors with experience in the power and energy sector to its board, noting that it has already identified five executives to guide the operational and strategic changes.